Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Expression profiling by high throughput sequencing | Stefano Beretta | ||||||
GSE144058 |
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis
|
|
22 | Stefano Beretta | May 14, 2021 | |||
GSE167021 |
Premature senescence and increased oxidative stress in the thymus of Down Syndrome patients
|
|
12 | Stefano Beretta | Dec 24, 2021 | |||
GSE168834 |
Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs (RNA-seq)
|
|
10 | Stefano Beretta | Sep 01, 2022 | |||
GSE173645 |
Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models [scRNA-seq]
|
|
9 | Stefano Beretta | Jun 01, 2022 | |||
GSE197417 |
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse [RNA-seq]
|
|
32 | Stefano Beretta | Feb 28, 2022 | |||
GSE197419 |
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse
|
|
72 | Stefano Beretta | Feb 28, 2022 | |||
GSE197761 |
Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models [Bulk RNA-seq]
|
|
18 | Stefano Beretta | Jun 01, 2022 | |||
GSE197762 |
Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models
|
|
27 | Stefano Beretta | Jun 01, 2022 | |||
GSE206902 |
Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs (NHEJ)
|
|
27 | Stefano Beretta | Sep 01, 2022 | |||
GSE206904 |
Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs.
|
|
73 | Stefano Beretta | Sep 01, 2022 | |||
GSE216248 |
Lipid Nanoparticles Allow Efficient and Harmless Ex Vivo Gene Editing of Human Hematopoietic Cells [RNAseq_electro]
|
|
33 | Stefano Beretta | Jun 30, 2023 | |||
GSE216249 |
Lipid Nanoparticles Allow Efficient and Harmless Ex Vivo Gene Editing of Human Hematopoietic Cells [RNAseq_lnps]
|
|
36 | Stefano Beretta | Jun 30, 2023 | |||
GSE216250 |
Lipid Nanoparticles Allow Efficient and Harmless Ex Vivo Gene Editing of Human Hematopoietic Cells
|
|
245 | Stefano Beretta | Jun 30, 2023 | |||
GSE218462 |
Genotoxic effects of base and prime editing in human hematopoietic stem cells [RNAseq_BaseEd]
|
|
39 | Stefano Beretta | Jul 18, 2023 | |||
GSE218463 |
Genotoxic effects of base and prime editing in human hematopoietic stem cells [RNAseq_PrimeEd]
|
|
6 | Stefano Beretta | Jul 18, 2023 | |||
GSE218464 |
Genotoxic effects of base and prime editing in human hematopoietic stem cells
|
|
717 | Stefano Beretta | Jul 18, 2023 | |||
GSE221357 |
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases [scRNA-seq]
|
|
8 | Stefano Beretta | Sep 27, 2023 | |||
GSE221359 |
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases [Visium]
|
|
8 | Stefano Beretta | Sep 27, 2023 | |||
GSE221360 |
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases
|
|
16 | Stefano Beretta | Sep 27, 2023 | |||
GSE236424 |
Spatiotemporal hepatocyte heterogeneity impacts in vivo gene engineering [Visium Spatial Transcriptomics]
|
|
23 | Stefano Beretta | Aug 01, 2023 |